Nutriband (NTRBW) Stock Analysis

What Nutriband does

Nutriband Inc. is a pharmaceutical company dedicated to advancing a diverse pipeline of transdermal drug products. Foremost among its developmental initiatives is an abuse-deterrent fentanyl transdermal system. This innovative patch aims to provide both healthcare providers and patients with an extended-release fentanyl solution for the effective management of chronic pain. Beyond its core transdermal portfolio, Nutriband Inc. also holds a licensing agreement with Rambam Med-Tech Ltd. for the development of RAMBAM Closed System Transfer Devices. Established in 2016, the company maintains its corporate headquarters in Orlando, Florida.

Key metrics

ETFs linked to NTRBW

Broad-market and Healthcare sector ETFs an investor holding Nutriband is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how NTRBW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Nutriband?

Nutriband trades under the ticker NTRBW on NASDAQ.

Which exchange is NTRBW listed on?

NTRBW is listed on NASDAQ.

What sector does Nutriband operate in?

Nutriband is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze NTRBW in a portfolio?

PortView shows NTRBW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.